Sonoma Pharmaceuticals, Inc.
SNOA
Revenue
3.39M
▼-48.00k▼-1.40%
3 Months ChangeAssets
13.67M
▼-1.07M▼-7.24%
3 Months ChangeLiabilities
8.70M
▲95.00k▲1.10%
3 Months ChangeFree Cash Flow
-917.00k
▼-685.00k▼-295.26%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-22
Form 8-K
ID: 0001683168-24-007283
2024-09-20
Form 8-K
ID: 0001683168-24-006556
2024-08-28
Form 8-K
ID: 0001683168-24-006053
2024-08-23
Form 8-K
ID: 0001683168-24-005980
2024-08-21
Form 8-K
ID: 0001683168-24-005938
2024-08-08
Form 10-Q
ID: 0001683168-24-005371
2024-06-27
Form 8-K
ID: 0001683168-24-004506
2024-04-09
Form 8-K
ID: 0001683168-24-002224
2024-04-02
Form 8-K
ID: 0001683168-24-002051
2024-03-22
Form 8-K
ID: 0001683168-24-001635